CO6831973A2 - Composición inmunogénica para modulación del sistema inmune y su uso, método de tratamiento y prevención de enfermedades, método para inducir la regeneración celular y procedimiento para la reconducción de la respuesta inmune - Google Patents

Composición inmunogénica para modulación del sistema inmune y su uso, método de tratamiento y prevención de enfermedades, método para inducir la regeneración celular y procedimiento para la reconducción de la respuesta inmune

Info

Publication number: CO6831973A2
Authority: CO; Colombia
Prior art keywords: reconduction; diseases; modulation; prevention; procedure
Prior art date: 2011-03-18

Application number

CO13246905A

Other languages

English (en)

Inventor

Alexandre Eduardo Nowill

Original Assignee

Alexandre Eduardo Nowill

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-03-18

Filing date

2013-10-17

Publication date

2014-01-10

2013-10-17 Application filed by Alexandre Eduardo Nowill filed Critical Alexandre Eduardo Nowill

2014-01-10 Publication of CO6831973A2 publication Critical patent/CO6831973A2/es

Links

238000000034 method Methods 0.000 title 3
230000006806 disease prevention Effects 0.000 title 1
230000028993 immune response Effects 0.000 title 1
210000000987 immune system Anatomy 0.000 title 1
230000002163 immunogen Effects 0.000 title 1
230000008929 regeneration Effects 0.000 title 1
238000011069 regeneration method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55533—IL-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Obesity (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Biomedical Technology (AREA)

CO13246905A 2011-03-18 2013-10-17 Composición inmunogénica para modulación del sistema inmune y su uso, método de tratamiento y prevención de enfermedades, método para inducir la regeneración celular y procedimiento para la reconducción de la respuesta inmune CO6831973A2 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
BRPI1100857-1A BRPI1100857A2 (pt)	2011-03-18	2011-03-18	agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real

Publications (1)

Publication Number	Publication Date
CO6831973A2 true CO6831973A2 (es)	2014-01-10

Family

ID=46829971

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CO13246905A CO6831973A2 (es)	2011-03-18	2013-10-17	Composición inmunogénica para modulación del sistema inmune y su uso, método de tratamiento y prevención de enfermedades, método para inducir la regeneración celular y procedimiento para la reconducción de la respuesta inmune

Country Status (16)

Country	Link
US (1)	US9566330B2 (es)
EP (1)	EP2687227B1 (es)
JP (2)	JP6181636B2 (es)
KR (1)	KR102008535B1 (es)
CN (1)	CN103717233B (es)
AU (1)	AU2012229902B2 (es)
BR (2)	BRPI1100857A2 (es)
CA (1)	CA2837348A1 (es)
CL (1)	CL2013002712A1 (es)
CO (1)	CO6831973A2 (es)
DK (1)	DK2687227T3 (es)
ES (1)	ES2699264T3 (es)
MX (1)	MX363050B (es)
PT (1)	PT2687227T (es)
RU (1)	RU2678317C2 (es)
WO (1)	WO2012122618A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10213504B2 (en)	2011-03-18	2019-02-26	Alexandre Eduardo Nowill	Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject
GB201112091D0 (en)	2011-07-14	2011-08-31	Gt Biolog Ltd	Bacterial strains isolated from pigs
GB201117313D0 (en)	2011-10-07	2011-11-16	Gt Biolog Ltd	Bacterium for use in medicine
GB201306536D0 (en)	2013-04-10	2013-05-22	Gt Biolog Ltd	Polypeptide and immune modulation
CN105636601A (zh)	2013-06-21	2016-06-01	翁德克控股有限公司	免疫治疗组合物及其用途
CN114740202A (zh)	2014-03-28	2022-07-12	欧普科诊断有限责任公司	与***癌的诊断有关的组合物和方法
KR101631312B1 (ko) *	2014-06-16	2016-06-20	연세대학교 산학협력단	재조합 람블편모충 결합 면역글로블린 단백질을 포함하는 면역증강 조성물
CN104546937B (zh) *	2014-09-30	2019-02-01	深圳华大基因科技有限公司	系结梭菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
EP3400953A1 (en)	2014-12-23	2018-11-14	4D Pharma Research Limited	Pirin polypeptide and immune modulation
KR102523805B1 (ko)	2014-12-23	2023-04-20	4디 파마 리서치 리미티드	면역 조정
DK3253800T3 (da)	2015-03-27	2021-05-31	Opko Diagnostics Llc	Prostata antigen standarder og bruge deraf
MA41010B1 (fr)	2015-06-15	2020-01-31	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
EA038405B1 (ru)	2015-06-15	2021-08-24	4Д Фарма Рисёрч Лимитед	ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ШТАММЫ БАКТЕРИИ Bifidobacterium breve, ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПАТОЛОГИЧЕСКОГО СОСТОЯНИЯ, ОПОСРЕДОВАННОГО IL-17 ИЛИ Th17
MA41060B1 (fr)	2015-06-15	2019-11-29	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
EA201890050A1 (ru)	2015-06-15	2018-06-29	4Д Фарма Рисёрч Лимитед	Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru)	2015-06-15	2018-06-29	4Д Фарма Рисёрч Лимитед	Композиции, содержащие бактериальные штаммы
NZ742787A (en)	2015-11-20	2020-02-28	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520497D0 (en)	2015-11-20	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520638D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520631D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201612191D0 (en)	2016-07-13	2016-08-24	4D Pharma Plc	Compositions comprising bacterial strains
DK3313423T3 (da)	2016-03-04	2019-05-20	4D Pharma Plc	Sammensætninger omfattende bakterielle blautia-stammer til behandling af visceral hypersensitivitet
TW201821093A (zh)	2016-07-13	2018-06-16	英商４Ｄ製藥有限公司	包含細菌菌株之組合物
GB201621123D0 (en)	2016-12-12	2017-01-25	4D Pharma Plc	Compositions comprising bacterial strains
KR20190139209A (ko) *	2017-02-13	2019-12-17	알렉산드레 에듀아르도 노윌	면역시스템을 조절하기 위한 면역원성 조성물 및 개체에서의 세균 감염 치료 방법
MA48940A (fr)	2017-05-22	2020-04-08	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
MA41708A (fr)	2017-05-24	2020-04-08	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
HUE052319T2 (hu)	2017-06-14	2021-04-28	4D Pharma Res Ltd	Baktériumtörzseket tartalmazó készítmények
WO2018229236A2 (en)	2017-06-14	2018-12-20	4D Pharma Research Limited	Compositions comprising bacterial strains
RU2699540C2 (ru) *	2017-08-17	2019-09-06	Павел Павлович Несмиянов	Композиция, содержащая пробиотические бактерии или их компоненты, и способ ее применения в лечении иммунных заболеваний кожи
WO2019152884A1 (en) *	2018-02-02	2019-08-08	University Of Washington	Compositions and methods for inducing tripartite motif-containing protein 16 (trim16) signaling
CN109010824A (zh) *	2018-08-27	2018-12-18	广州汇高生物科技有限公司	一种特异性卵黄免疫球蛋白组合物及其制剂
WO2020106158A1 (en) *	2018-11-20	2020-05-28	Acd Pharmaceuticals As	Serratia liquefaciens variant
ES2962407T3 (es) *	2018-12-04	2024-03-18	Sabiotec Spin Off S L	Inmunoestimulante para su uso contra patógenos
CN110156885B (zh) *	2019-05-23	2020-11-24	南京林业大学	松材线虫的病原相关模式分子蛋白BxCDP1及其应用
WO2022040768A1 (en) *	2020-08-28	2022-03-03	Nowill Alexandre Eduardo	Compositions for uses in methods of treating coronavirus infections
CN113244273A (zh) *	2021-03-16	2021-08-13	广州中科蓝华生物科技有限公司	疟原虫在制备联合放射疗法用于抗肿瘤的制剂中的应用
CN114606317B (zh) *	2022-03-22	2022-12-02	中山大学附属第一医院	一种预测胃癌***转移的菌群标志物及其应用
DE202023103094U1 (de)	2023-06-06	2023-06-30	Dasari Chandransh	Ein System zur Regeneration menschlicher Zellen mit isoliertem regenerativem Gen eines Planarienorganismus

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5595756A (en) *	1993-12-22	1997-01-21	Inex Pharmaceuticals Corporation	Liposomal compositions for enhanced retention of bioactive agents
AU737337B2 (en) *	1998-02-05	2001-08-16	Smithkline Beecham Biologicals (Sa)	Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
US6432710B1 (en) *	1998-05-22	2002-08-13	Isolagen Technologies, Inc.	Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
AT410635B (de) *	2000-10-18	2003-06-25	Cistem Biotechnologies Gmbh	Vakzin-zusammensetzung
WO2004096270A1 (en) *	2003-04-30	2004-11-11	Medi Service S.R.L.	Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates
WO2005077408A2 (en) *	2004-02-06	2005-08-25	Vaxinnate Corporation	Compositions of pamps and listeria monocytogenes and methods of use
PL1765391T3 (pl) *	2004-06-07	2013-08-30	Qu Biologics Inc	Kompozycje bakteryjne do leczenia nowotworów
JP2008544949A (ja) *	2004-10-08	2008-12-11	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	化膿性レンサ球菌のための免疫激性組成物および治療用組成物
JP2009544322A (ja) *	2006-07-27	2009-12-17	リゴサイトファーマシューティカルズインコーポレイテッド	キメラウイルス様粒子
EP2061800B1 (en) *	2006-08-15	2015-07-29	The Trustees of the University of Pennsylvania	Compositions comprising hmw-maa and fragments thereof, and methods of use thereof
EP1938835A1 (en) *	2006-12-29	2008-07-02	Pevion Biotech AG	Non-specific immunostimulating agents
WO2009073133A1 (en) *	2007-11-29	2009-06-11	Vaxinnate Corporation	Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof
AU2009266940A1 (en) *	2008-07-01	2010-01-07	Emory University	Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors
US10369204B2 (en) *	2008-10-02	2019-08-06	Dako Denmark A/S	Molecular vaccines for infectious disease
AU2009316680B2 (en) *	2008-11-18	2016-03-24	Takeda Vaccines, Inc.	RSV F VLPs and methods of manufacture and use thereof

2011
- 2011-03-18 BR BRPI1100857-1A patent/BRPI1100857A2/pt not_active Application Discontinuation
2012
- 2012-03-19 ES ES12757249T patent/ES2699264T3/es active Active
- 2012-03-19 JP JP2014500207A patent/JP6181636B2/ja active Active
- 2012-03-19 BR BR112013023773A patent/BR112013023773B8/pt active IP Right Grant
- 2012-03-19 CN CN201280024132.7A patent/CN103717233B/zh active Active
- 2012-03-19 EP EP12757249.3A patent/EP2687227B1/en active Active
- 2012-03-19 DK DK12757249.3T patent/DK2687227T3/en active
- 2012-03-19 PT PT12757249T patent/PT2687227T/pt unknown
- 2012-03-19 WO PCT/BR2012/000072 patent/WO2012122618A1/pt active Application Filing
- 2012-03-19 RU RU2013143400A patent/RU2678317C2/ru active
- 2012-03-19 MX MX2013010669A patent/MX363050B/es unknown
- 2012-03-19 US US14/006,077 patent/US9566330B2/en active Active
- 2012-03-19 CA CA2837348A patent/CA2837348A1/en not_active Abandoned
- 2012-03-19 AU AU2012229902A patent/AU2012229902B2/en active Active
- 2012-03-19 KR KR1020137027403A patent/KR102008535B1/ko active IP Right Grant
2013
- 2013-09-23 CL CL2013002712A patent/CL2013002712A1/es unknown
- 2013-10-17 CO CO13246905A patent/CO6831973A2/es unknown
2017
- 2017-02-24 JP JP2017033884A patent/JP2017132776A/ja active Pending

Also Published As

Publication number	Publication date
US20140037716A1 (en)	2014-02-06
MX363050B (es)	2019-03-06
WO2012122618A1 (pt)	2012-09-20
KR20140027162A (ko)	2014-03-06
EP2687227A1 (en)	2014-01-22
CN103717233B (zh)	2020-05-26
EP2687227B1 (en)	2018-08-22
CN103717233A (zh)	2014-04-09
RU2013143400A (ru)	2015-04-27
ES2699264T3 (es)	2019-02-08
CA2837348A1 (en)	2012-09-20
BRPI1100857A2 (pt)	2013-05-21
US9566330B2 (en)	2017-02-14
WO2012122618A8 (pt)	2012-11-08
DK2687227T3 (en)	2018-12-10
AU2012229902A1 (en)	2013-11-07
JP2014508783A (ja)	2014-04-10
JP6181636B2 (ja)	2017-08-16
BR112013023773A2 (pt)	2020-11-10
CL2013002712A1 (es)	2014-08-18
AU2012229902B2 (en)	2017-06-29
NZ616823A (en)	2016-08-26
PT2687227T (pt)	2018-12-11
MX2013010669A (es)	2014-10-14
BR112013023773B8 (pt)	2022-10-18
BR112013023773B1 (pt)	2022-09-20
RU2678317C2 (ru)	2019-01-28
EP2687227A4 (en)	2014-10-01
JP2017132776A (ja)	2017-08-03
KR102008535B1 (ko)	2019-10-21

Publication	Publication Date	Title
CO6831973A2 (es)	2014-01-10	Composición inmunogénica para modulación del sistema inmune y su uso, método de tratamiento y prevención de enfermedades, método para inducir la regeneración celular y procedimiento para la reconducción de la respuesta inmune
CO6940374A2 (es)	2014-05-09	Composiciones, usos y métodos para tratamiento de trastornos y enfermedades metabólicas
CL2014002903A1 (es)	2015-02-06	Composición geopolimérica de aluminosilicato; método de preparacion y sus usos.
ZA201504952B (en)	2016-07-27	Human antibodies to respiratory syncytial virus f protein and methods
PL2917229T3 (pl)	2021-01-11	Przeciwciała i ich fragmenty aktywowane przeciwko domenie alfa-3 białka HLA-G, sposoby i środki ich wytwarzania oraz ich zastosowania
AR090903A1 (es)	2014-12-17	Anticuerpos e inmunoconjugados anti-pmel17
AR089993A1 (es)	2014-10-01	Macrociclos peptidomimeticos
BR112015006652A2 (pt)	2017-08-08	método e sistema para procedimentos cosméticos de pele para uso doméstico.
BR112014023937A2 (pt)	2018-04-17	composição farmacêutica, agente farmacêutico de combinação e método de tratamento
BR112013033811A2 (pt)	2017-02-14	composição, método de preparação da composição, e, composto
BR112015002541A2 (pt)	2017-12-05	composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente.
BR112015002755A2 (pt)	2017-07-04	derivado de ácido hialurônico, método de preparação de derivado de ácido hialurônico, método de modificação de derivado de ácido hialurônico e uso de derivados
PT2848097T (pt)	2021-10-28	Dispositivo para o tratamento de plasma de superfícies humanas, animais ou de plantas, em particular da pele ou de áreas de membrana mucosa
PL2934592T3 (pl)	2018-12-31	C6-c18-acylowana pochodna kwasu hialuronowego, sposób jej wytwarzania, mieszanina nanomicelarna na jej bazie, sposób jej wytwarzania oraz sposób wytwarzania stabilizowanej mieszanki nanomicelarnej i jej zastosowanie
BR112014001962A2 (pt)	2017-02-21	dispositivo, sistema e método para restauração prostodôntica
FI20130087L (fi)	2013-03-26	Patjan rakenne, patjajärjestelmä ja patjan käyttötapa
BR112014010538A2 (pt)	2017-04-25	artigo de filtro, e, sistema para o tratamento de um gás de escape
CL2015000489A1 (es)	2015-10-02	Sistema y metodo para tratamiento de agua
CO7000778A2 (es)	2014-07-21	Derivados de pirazolopiridina, su procedimiento de preparación y su uso terapéutico
WO2012129341A3 (en)	2012-12-06	Disease detection in plants
BR112013034055A2 (pt)	2017-02-07	alcaftadina para uso no tratamento de urticária
DK2825181T3 (da)	2020-04-14	Porøse carbonpartikler til anvendelse i behandling eller forebyggelse af leversygdom
HK1224184A1 (zh)	2017-08-18	用於治療炎性疾病的化合物、藥物組合物和方法
ITTO20110634A1 (it)	2012-01-22	Metodo per trattare patologie organiche del sistema nervoso, la sindrome psicoorganica e l'encefalopatia
CL2015001689A1 (es)	2016-09-09	Parvovirus 5a porcino, métodos de uso y vacuna